Vanguard PRIMECAP Core Fund Investor Shares (VPCCX)

Fund Assets	15.27B
Expense Ratio	0.45%
Min. Investment	$3,000
Turnover	11.00%
Dividend (ttm)	6.39
Dividend Yield	13.57%
Dividend Growth	166.42%
Payout Frequency	Annual
Ex-Dividend Date	Dec 17, 2025

Previous Close	47.07
YTD Return	27.49%
1-Year Return	63.70%
5-Year Return	114.76%
52-Week Low	34.05
52-Week High	47.21
Beta (5Y)	1.00
Holdings	185
Inception Date	Dec 9, 2004

About VPCCX

This fund, similar to its sibling, PRIMECAP Fund, is managed with a long-term perspective, extremely low turnover, and a well-established investment strategy. The difference is that this fund invests in stocks with both value and growth characteristics, while PRIMECAP focuses on growth-oriented stocks. One risk to note is that the fund may become concentrated in a few sectors, notably technology and health care. Short-term performance may be volatile when these sectors are strongly in or out of favor. This fund may be considered a complement to an already diversified portfolio with a long-term time horizon.

• Fund Family: Vanguard
• Category: Large Blend
• Performance Rating: Average
• Risk Rating: Above Average
• Stock Exchange: NASDAQ
• Ticker Symbol: VPCCX
• Share Class: Investor Shares
• Index: MSCI US Prime Market 750 TR

Performance

VPCCX had a total return of 63.70% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.91%.

Top 10 Holdings

30.42% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	5.43%
Micron Technology, Inc.	MU	4.03%
AstraZeneca PLC	AZN	3.47%
Alphabet Inc.	GOOGL	2.97%
Flex Ltd.	FLEX	2.97%
Intel Corporation	INTC	2.84%
KLA Corporation	KLAC	2.44%
Microsoft Corporation	MSFT	2.18%
Mktliq 12/31/2049	n/a	2.17%
Amgen Inc.	AMGN	1.92%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 17, 2025	$6.38894	Dec 18, 2025
Dec 18, 2024	$2.3981	Dec 19, 2024
Dec 19, 2023	$1.8173	Dec 20, 2023
Dec 19, 2022	$2.283	Dec 20, 2022
Dec 20, 2021	$2.3178	Dec 21, 2021
Dec 21, 2020	$2.2879	Dec 22, 2020